Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue:
Licensing revenue
Expenses:
Research and development	4,463	14,625	628,543	14,625
General and administrative	823,250	825,688	2,325,636	2,926,892
Loss from operations	(827,713)	(840,313)	(2,954,179)	(2,941,517)
Other income:
Interest income	3,173	24,307	33,386	31,405
Sale of royalty and milestone rights, net of transaction costs			1,000,000	4,167,219
Other		17		1,372
Net income (loss)	(824,540)	(815,989)	(1,920,793)	1,258,479
Dividends paid on preferred shares				(68,809)
Net income (loss) attributable to common stockholders	$ (824,540)	$ (815,989)	$ (1,920,793)	$ 1,189,670
Total basic income (loss) per share	$ (1.67)	$ (1.65)	$ (3.88)	$ 2.59
Total diluted income (loss) per share	$ (1.67)	$ (1.65)	$ (3.88)	$ 2.59
Basic weighted-average shares outstanding	495,092	495,092	495,092	486,101
Diluted weighted-average shares outstanding	495,092	495,092	495,092	486,101